Owen Adams Catherine — SEC Form 4 filings
SEC reporting owner CIK 1816838. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-07 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 11,641 shares, $249,932 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 11,641 shares @ $21.47 ($249,932) in ACADIA PHARMACEUTICALS INC, filed 2026-03-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | Chief Executive Officer, Director | 4 | — | 1 leg · 11,641 sh · $249,932 | 7 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | 6 | — | — | 16 |
| OptiNose, Inc. (OPTN) | Director | 1 | — | — | 1 |
Form 4 filings — Owen Adams Catherine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,816 @ $0 · Option exercise (M): 2,816 (derivative) @ $0 · Grant/award (A): 2,927 (derivative) @ $0 · Grant/award (A): 14,950 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,976 @ $0 · Option exercise (M): 1,976 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 23,509 @ $0 · Sale (S): 11,641 @ $21.47 · Option exercise (M): 23,509 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 263,005 (derivative) @ $0 · Grant/award (A): 76,509 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,120 @ $0 · Grant/award (A): 2,816 (derivative) @ $0 · Grant/award (A): 15,768 (derivative) @ $0 · Option exercise (M): 2,120 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,977 @ $0 · Option exercise (M): 1,977 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 319,976 (derivative) @ $0 · Grant/award (A): 94,039 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 353,261 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/award (A): 2,120 (derivative) @ $0 · Grant/award (A): 11,774 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,976 @ $0 · Option exercise (M): 1,976 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | OptiNose, Inc. (OPTN) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816838 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →